Carson Wealth (CWM LLC)’s FibroBiologics FBLG Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio FBLG Stock Details FBLG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-13	Closed	–	–	5690
2025 Q3	$0	Sell	13 -168	-93%	-$2.01K	﹤0.01%	5592
2025 Q2	$2K	Buy	181 +19	+12%	+$343	﹤0.01%	4946
2025 Q1	$3K	Buy	162 +156	+2,600%	+$4.46K	﹤0.01%	4704
2024 Q4	$0	Buy	6 +1	+20%	+$54	﹤0.01%	5207
2024 Q3	$0	Buy	+5	New	+$332	﹤0.01%	5203

Other funds holding FBLG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CFP

Cascade Financial Partners San Diego, California $1.15B AUM 33.6% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

ANTB

AMG National Trust Bank Greenwood Village, Colorado $4.88B AUM 24.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Carson Wealth (CWM LLC)'s FBLG Position: Q4 2025 in Review

Carson Wealth (CWM LLC) sold out of FibroBiologics (FBLG) in Q4 2025, closing a stake of 13 shares.

Carson Wealth (CWM LLC) first reported a position in FBLG in Q3 2024 and held it in 5 quarters. The position peaked at $3K in Q1 2025. 45 funds tracked by Wall St. Rank hold FBLG as of Q4 2025.

Carson Wealth (CWM LLC) reported no remaining FibroBiologics position as of Q4 2025 after selling out during the quarter.
Carson Wealth (CWM LLC) sold 13 FibroBiologics shares in Q4 2025.
Carson Wealth (CWM LLC) first reported a position in FibroBiologics in Q3 2024 and held it in 5 quarters.
Carson Wealth (CWM LLC)'s FibroBiologics position peaked at $3K in Q1 2025.
45 funds tracked by Wall St. Rank held FibroBiologics as of Q4 2025.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q4 2025, filed 26 Jan 2026.